Transdiagnostic Cognitive Biomarkers
- Conditions
- DepressionPain
- Interventions
- Behavioral: Computer game/taskBehavioral: Health surveys online
- Registration Number
- NCT04864080
- Lead Sponsor
- University of Minnesota
- Brief Summary
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
- Detailed Description
This study aims to test the feasibility of procedures aimed at discovering transdiagnostic biomarkers for cognitive impairment in chronic pain and depression. Fifteen healthy control participants and 15 participants from each disease group (chronic pain, depression) will be recruited.
Using a task-based fmri, TMS will be targeted for priming of the Left DLPFC. EEG will be used during our behavioral paradigm to compare changes in DLPFC function before and after primed TMS.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 45
- Have access to the online study platform.
- under 18, non-English speaking
Arm 2: pain and depression:
Inclusion Criteria:
- Pain or depression
Exclusion Criteria:
- pregnant women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Healthy Comparison Group Computer game/task Behavioral tasks and surveys online. Healthy Comparison Group Health surveys online Behavioral tasks and surveys online. Pain/Depression patients from clinic Health surveys online MRI, TMS and EEG, and behavioral tasks and surveys online. Pain/Depression patients from clinic Computer game/task MRI, TMS and EEG, and behavioral tasks and surveys online.
- Primary Outcome Measures
Name Time Method Feasibility for all aspects of the study 1-7 days Feasibility; the overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.
- Secondary Outcome Measures
Name Time Method Acceptability 1-7 days Sum total of acceptability rating scale of study procedures.
Trial Locations
- Locations (1)
University of Minnesota
🇺🇸Minneapolis, Minnesota, United States